Patents by Inventor Tony Tsz-Cheong Ng

Tony Tsz-Cheong Ng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phosphocofilin: cofilin co-localization intensity as a predictor of metastatic recurrence
    Patent number: 11169154
    Abstract: Methods and products are provided for determining if a subject having a tumor is at risk of metastasis of the tumor. Specifically, the methods comprise detecting phosphorylated cofilin, and both phosphorylated and non-phosphorylated cofilin; quantifying the phosphorylated cofilin, and the total of phosphorylated and nonphosphorylated cofilin; and determining if a subject having the tumor is likely to experience metastasis of the tumor, based on the ratio of the amount of detected phosphorylated cofilin:total amount of phosphorylated and non-phosphorylated cofilin detected. Further disclosed are the types of tumor metastases that can be determined using the methods provided.
    Type: Grant
    Filed: July 24, 2018
    Date of Patent: November 9, 2021
    Assignees: ALBERT EINSTEIN COLLEGE OF MEDICINE, KING'S COLLEGE LONDON
    Inventors: John Condeelis, Tony Tsz-Cheong Ng, Gregory Weitsman
  • PHOSPHOCOFILIN: COFILIN CO-LOCALIZATION INTENSITY AS A PREDICTOR OF METASTATIC RECURRENCE
    Publication number: 20190011448
    Abstract: Methods and products are provided for determining if a subject having a tumor is at risk of metastasis of the tumor. Specifically, the methods comprise detecting phosphorylated cofilin, and both phosphorylated and non-phosphorylated cofilin; quantifying the phosphorylated cofilin, and the total of phosphorylated and nonphosphorylated cofilin; and determining if a subject having the tumor is likely to experience metastasis of the tumor, based on the ratio of the amount of detected phosphorylated cofilin:total amount of phosphorylated and non-phosphorylated cofilin detected. Further disclosed are the types of tumor metastases that can be determined using the methods provided.
    Type: Application
    Filed: July 24, 2018
    Publication date: January 10, 2019
    Applicants: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC., KING'S COLLEGE LONDON
    Inventors: John Condeelis, Tony Tsz-Cheong Ng, Gregory Weitsman
  • PHOSPHOCOFILIN: COFILIN CO-LOCALIZATION INTENSITY AS A PREDICTOR OF METASTATIC RECURRENCE
    Publication number: 20150104442
    Abstract: Methods and products are provided for determining if a subject having a tumor is at risk of metastasis of the tumor. Specifically, the methods comprise detecting phosphorylated cofilin, and both phosphorylated and non-phosphorylated cofilin; quantifying the phosphorylated cofilin, and the total of phosphorylated and nonphosphorylated cofilin; and determining if a subject having the tumor is likely to experience metastasis of the tumor, based on the ratio of the amount of detected phosphorylated cofilin: total amount of phosphorylated and non-phosphorylated cofilin detected. Further disclosed are the types of tumor metastases that can be determined using the methods provided.
    Type: Application
    Filed: August 14, 2012
    Publication date: April 16, 2015
    Applicants: King's College London, Albert Einstein College Of medicine of Yeshiva University
    Inventors: John Condeelis, Tony Tsz-Cheong Ng, Gregory Weitsman